Utility of myxedema score as a predictor of mortality in myxedema coma
- PMID: 35945394
- DOI: 10.1007/s40618-022-01884-6
Utility of myxedema score as a predictor of mortality in myxedema coma
Abstract
Objective: Myxedema crisis (MC) is a rare condition. There is a dearth of data regarding the predictors of mortality in MC. Predictive scores for mortality specific to the clinical and biochemical profile of MC are still lacking.
Design and methods: All consecutive patients presenting with MC from September 2006 to December 2020 comprised the new cohort. Patients managed between January 1999 and August 2006 comprised the old cohort. Both cohorts were compared for the determination of secular trends. Combined analysis of both the cohorts was done for clinico-demographic profile and predictors of mortality. Myxedema score (MS) and qSOFA (Quick Sequential Organ Failure Assessment) score were evaluated in all the patients.
Results: A total of forty-one patients (new cohort; n = 18 and old cohort; n = 23) were enrolled into the study. There was a female predominance (80.5%). Nearly half (51.2%) of the patients were newly diagnosed with hypothyroidism on admission. Overall mortality was 60.9%. On comparative analysis among survivors and non-survivors, female gender (OR 20.4, p value 0.018), need for mechanical ventilation (OR16.4, p value 0.009), in-hospital hypotension (OR 9.1, p value 0.020), and high qSOFA score (OR 7.1, p value 0.023) predicted mortality. MS of > 90 had significantly higher mortality (OR-11.8, p value - 0.026) while MS of > 110 had 100% mortality. There was no change in secular trends over last 20 years. There was no difference in outcome of patients receiving oral or IV levothyroxine.
Conclusion: Myxedema crisis is associated with high mortality despite improvement in health care services. The current study is first to elucidate the role of the MS in predicting mortality in patients with MC.
Keywords: IV levothyroxine; Myxedema coma; Myxedema score; Predictors of mortality; qSOFA score.
© 2022. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).
References
-
- Wartofsky L (2006) Myxedema coma. Endocrinol Metab Clin North Am 35:687–698 - DOI
-
- Reinhardt W, Mann K. Incidence, clinical picture and treatment of hypothyroid coma. Results of a survey. Medizinische Klinik (Munich, Germany: 1983) 1997 92 521–524.
-
- Ono Y, Ono S, Yasunaga H, Matsui H, Fushimi K, Tanaka Y (2017) Clinical characteristics and outcomes of myxedema coma: analysis of a national inpatient database in Japan. J Epidemiol 27:117–122 - DOI
-
- Rodriguez I, Fluiters E, Perez-Mendez LF, Luna R, Páramo C, García Mayor RV. Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single. Journal of Endocrinology 2004 180 50.
-
- Bridwell RE, Willis GC, Gottlieb M, Koyfman A, Long B. Decompensated hypothyroidism: a review for the emergency clinician. The American Journal of Emergency Medicine 2020 Sep 30.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
